Virtuoso Therapeutics, Inc.
PrivateLast Round
Series A
Mar 1, 2019
Company Overview
Virtuoso Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in San Mateo, California. Its latest recorded funding round was a Series A round in March 2019.
Virtuoso Therapeutics, Inc. is a biotechnology company developing novel bispecific antibody therapies designed to improve efficacy and overcome limitations of existing cancer treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Virtuoso Therapeutics, Inc. Comparables
Compare Virtuoso Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Amberstone Biosciences | 88% | |
| QLSF Biotherapeutics | 86% | |
| Phanes Therapeutics | 85% |
For institutional investors. Book with your work email.
Virtuoso Therapeutics, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Virtuoso Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cenova Capital | Series A |
| Canaan Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2019
Raised Series A with Canaan Partners, WuXi Biologics, and Cenova Capital.
For institutional investors. Book with your work email.
Virtuoso Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Virtuoso Therapeutics, Inc.'s valuation, stock price, and market status.
Is Virtuoso Therapeutics, Inc. a public or private company?
Virtuoso Therapeutics, Inc. is a private company.
What is the current stock price of Virtuoso Therapeutics, Inc.?
Virtuoso Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Virtuoso Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Virtuoso Therapeutics, Inc. worth (valuation)?
Valuation information for Virtuoso Therapeutics, Inc. is not publicly available.
Can I buy Virtuoso Therapeutics, Inc. stock?
Virtuoso Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Virtuoso Therapeutics, Inc.'s last funding round?
Virtuoso Therapeutics, Inc.'s most recent funding round was Series A on March 1, 2019.
Who are the main investors in Virtuoso Therapeutics, Inc.?
Key investors in Virtuoso Therapeutics, Inc. include Cenova Capital, Canaan Partners.
Will Virtuoso Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Virtuoso Therapeutics, Inc..
How can I track Virtuoso Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Virtuoso Therapeutics, Inc.'s shares on secondary markets.